CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.01−0.38 (-0.79%)
Close on Nov 18, 2026Market cap $1.43BP/E 19.8Yield 1.25%
Conmed revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Conmed's revenue for the twelve months ending Sep 30, 2026 was $1.37B, up 1.6% year over year. For fiscal 2025 it was $1.37B, up 5.2% from the year before. Over ten years it grew 6.7% a year on average. The highest annual figure on record is $1.37B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.37B | +5.2% |
| FY2024 | Dec 31, 2024 | $1.31B | +5.0% |
| FY2023 | Dec 31, 2023 | $1.24B | +19.1% |
| FY2022 | Dec 31, 2022 | $1.05B | +3.4% |
| FY2021 | Dec 31, 2021 | $1.01B | +17.2% |
| FY2020 | Dec 31, 2020 | $862.46M | -9.7% |
| FY2019 | Dec 31, 2019 | $955.10M | +11.1% |
| FY2018 | Dec 31, 2018 | $859.63M | +7.9% |
| FY2017 | Dec 31, 2017 | $796.39M | +4.3% |
| FY2016 | Dec 31, 2016 | $763.52M | +6.2% |
| FY2015 | Dec 31, 2015 | $719.17M | -2.8% |
| FY2014 | Dec 31, 2014 | $740.06M | -3.0% |
| FY2013 | Dec 31, 2013 | $762.70M | -0.6% |
| FY2012 | Dec 31, 2012 | $767.14M | +5.8% |
| FY2011 | Dec 31, 2011 | $725.08M | +1.6% |
| FY2010 | Dec 31, 2010 | $713.72M | +2.7% |
| FY2009 | Dec 31, 2009 | $694.74M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $335.56M | -0.7% |
| Q2 FY2026 | Jun 30, 2026 | $343.49M | +0.3% |
| Q1 FY2026 | Mar 31, 2026 | $317.05M | -1.3% |
| Q4 FY2025 | Dec 31, 2025 | $373.20M | +7.9% |
| Q3 FY2025 | Sep 30, 2025 | $337.93M | +6.7% |
| Q2 FY2025 | Jun 30, 2025 | $342.35M | +3.1% |
| Q1 FY2025 | Mar 31, 2025 | $321.26M | +2.9% |
| Q4 FY2024 | Dec 31, 2024 | $345.94M | +5.8% |
| Q3 FY2024 | Sep 30, 2024 | $316.70M | +4.0% |
| Q2 FY2024 | Jun 30, 2024 | $332.10M | +4.5% |
| Q1 FY2024 | Mar 31, 2024 | $312.27M | +5.7% |
| Q4 FY2023 | Dec 31, 2023 | $327.05M | +30.4% |
| Q3 FY2023 | Sep 30, 2023 | $304.58M | +10.7% |
| Q2 FY2023 | Jun 30, 2023 | $317.65M | +14.6% |
| Q1 FY2023 | Mar 31, 2023 | $295.47M | +21.9% |
| Q4 FY2022 | Dec 31, 2022 | $250.87M | -8.4% |
| Q3 FY2022 | Sep 30, 2022 | $275.09M | +10.6% |
| Q2 FY2022 | Jun 30, 2022 | $277.19M | +8.6% |
| Q1 FY2022 | Mar 31, 2022 | $242.33M | +4.1% |
| Q4 FY2021 | Dec 31, 2021 | $273.97M | +8.4% |
| Q3 FY2021 | Sep 30, 2021 | $248.83M | +4.6% |
| Q2 FY2021 | Jun 30, 2021 | $255.16M | +61.7% |
| Q1 FY2021 | Mar 31, 2021 | $232.68M | +8.7% |
| Q4 FY2020 | Dec 31, 2020 | $252.83M | -4.5% |
| Q3 FY2020 | Sep 30, 2020 | $237.84M | +1.8% |
| Q2 FY2020 | Jun 30, 2020 | $157.79M | -33.8% |
| Q1 FY2020 | Mar 31, 2020 | $214.01M | -2.0% |
| Q4 FY2019 | Dec 31, 2019 | $264.87M | +9.2% |
| Q3 FY2019 | Sep 30, 2019 | $233.59M | +15.5% |
| Q2 FY2019 | Jun 30, 2019 | $238.26M | +12.0% |
| Q1 FY2019 | Mar 31, 2019 | $218.38M | +8.1% |
| Q4 FY2018 | Dec 31, 2018 | $242.44M | +8.9% |
| Q3 FY2018 | Sep 30, 2018 | $202.31M | +6.4% |
| Q2 FY2018 | Jun 30, 2018 | $212.82M | +7.9% |
| Q1 FY2018 | Mar 31, 2018 | $202.06M | +8.3% |
| Q4 FY2017 | Dec 31, 2017 | $222.56M | +9.0% |
| Q3 FY2017 | Sep 30, 2017 | $190.12M | – |
| Q2 FY2017 | Jun 30, 2017 | $197.15M | – |
| Q1 FY2017 | Mar 31, 2017 | $186.57M | – |
| Q4 FY2016 | Dec 31, 2016 | $204.09M | – |
See a number that looks wrong?